+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Pathophysiology of type 2 diabetes mellitus in children and adolescents: treatment implications



Pathophysiology of type 2 diabetes mellitus in children and adolescents: treatment implications



Treatments in Endocrinology 1(6): 359-371



Type 2 diabetes mellitus was considered an exclusive disease of adulthood until the late 1970s, when reports of an increased prevalence in the pediatric age group emerged in the literature. The concerning upswing in the rate of diagnosis of type 2 diabetes mellitus in children and adolescents has continued, parallel to the increasing rates of obesity. The disease is not specific to the U.S.; it has proven to be a global problem. The current information on type 2 diabetes mellitus in children and adolescents is mostly extrapolated from studies in adults with type 2 diabetes mellitus, due to the paucity of studies conducted in youth. Obesity, family history of type 2 diabetes mellitus, minority ethnicity and race, polycystic ovary syndrome, maternal diabetes mellitus or impaired glucose tolerance during gestation, and acanthosis nigricans are the major risk factors and markers of youth-onset type 2 diabetes mellitus. The pathophysiology, which involves both an insulin secretion defect and resistance to insulin, needs further clarification in pediatric studies. Current management approaches involve lifestyle modification (nutritional and exercise) along with pharmacologic agents, such as insulin and oral antihyperglycemic medications, as indicated. A recent study on the use of metformin in childhood-onset type 2 diabetes mellitus demonstrated the drug to be effective and to have a good safety profile in this population. However, the outcomes of ongoing studies and future studies focusing on type 2 diabetes mellitus in the pediatric age group will be crucial in terms of fine-tuning management plans and setting up appropriate prevention strategies.

(PDF emailed within 1 workday: $29.90)

Accession: 049871106

Download citation: RISBibTeXText

PMID: 15832489


Related references

The pathophysiology of type ii noninsulin dependent diabetes mellitus implications for treatment. Rifkin, H And D Porte, Jr (Ed ) Ellenberg And Rifkin's Diabetes Mellitus: Theory And Practice, Fourth Edition Xvi+972p Elsevier Science Publishing Co , Inc : New York, New York, Usa; Amsterdam, Netherlands Illus 436-456, 1990

Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine 43(3): 504-513, 2013

Pathophysiology, diagnosis and treatment of type 2 diabetes mellitus in children and adolescent. Nihon Rinsho. Japanese Journal of Clinical Medicine 70 Suppl 5: 31-37, 2013

Treatment of type 2 diabetes mellitus in children and adolescents. Journal of Pediatric Endocrinology and Metabolism 13 Suppl 6: 1403-1409, 2001

Treatment of type 1 diabetes mellitus in children and adolescents. La Revue du Praticien 46(5): 577-586, 1996

Type II diabetes mellitus during GH treatment for children and adolescents The KIGS experience. Hormone Research (Basel) 50(SUPPL 3): 47, Sept, 1998

Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus. Pediatric Diabetes 3(2): 113-124, 2004

The treatment and prevention of diabetic ketoacidosis in children and adolescents with type I diabetes mellitus. Pediatric Annals 28(9): 576-582, 1999

Asymptomatic cardiomyopathy in children and adolescents with type 1 diabetes mellitus: association of echocardiographic indicators with duration of diabetes mellitus and metabolic parameters. Journal of Pediatric Endocrinology & Metabolism 19(5): 713-726, 2006

The potential role of insulin analogues in the treatment of children and adolescents with Type 1 diabetes mellitus. Diabetes, Nutrition and Metabolism 14(6): 349-357, 2002

Treatment intensification without improved HbA1c levels in children and adolescents with Type 1 diabetes mellitus. Diabetic Medicine 33(4): 515-522, 2016

Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism 15(7): 1005-1010, 2002

Pediatricians' perceptions and practices regarding prevention and treatment of type 2 diabetes mellitus in children and adolescents. Archives of Pediatrics and Adolescent Medicine 157(9): 913-918, 2003

Type 2 diabetes mellitus in children and adolescents: where do we stand with drug treatment and behavioral management?. Current Diabetes Reports 8(5): 383-388, 2008

A study of variability in glycaemia in children and adolescents with diabetes mellitus type 1 on treatment with insulin glargine. Anales de Pediatria 69(5): 426-431, 2009